Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is an aggressive and lethal cancer with a low 5 year survival rate. Identification of new therapeutic targets and its inhibitors remain essential for ESCC prevention and treatment. METHODS: TYK2 protein levels were checked by immunohistochemistry...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Xuechao, Huang, Chuntian, Hu, Yamei, Wu, Qiong, Liu, Fangfang, Nie, Wenna, Chen, Hanyong, Li, Xiang, Dong, Zigang, Liu, Kangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972218/
https://www.ncbi.nlm.nih.gov/pubmed/33731185
http://dx.doi.org/10.1186/s13046-021-01903-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972218/
https://www.ncbi.nlm.nih.gov/pubmed/33731185
http://dx.doi.org/10.1186/s13046-021-01903-z

Ejemplares similares